Drug intelligence / Profile preview

Serpina

Development stage
Unknown
Lead developer
Himalaya Wellness Company
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Serpina is a proprietary Ayurvedic herbal formulation developed and manufactured by Himalaya Wellness Company. Launched in 1934 as the world's first natural anti-hypertensive drug, Serpina is prepared from the root extract of *Rauwolfia serpentina* (commonly known as Sarpagandha or Indian snakeroot). The primary active alkaloid in the extract is reserpine, which acts as an irreversible inhibitor of vesicular monoamine transporters 1 and 2 (VMAT1 and VMAT2). By blocking VMAT, Serpina prevents the vesicular uptake and storage of monoamine neurotransmitters (such as norepinephrine, dopamine, and serotonin), leading to their depletion in presynaptic terminals. This depletion decreases peripheral sympathetic adrenergic tone, reduces peripheral vascular resistance, and lowers cardiac output, thereby effectively reducing blood pressure. Serpina is primarily indicated for the management of mild to moderate hypertension and is also utilized for its calming, sedative, and anxiolytic properties to manage anxiety disorders.

Brand names
Serpina
Other names
Rauvolfia serpentina root extractRauwolfia serpentina root extractSarpagandha
02

Targets

VMAT2 (Vesicular monoamine transporter 2)VMAT1 (Vesicular monoamine transporter type 1)

Beyond the preview

Go deeper on Serpina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serpina.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call